Iclabsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-12-31
Share capital
50 000,00 PLN
Registered address
ul. Wyżynna 8H, 30-617 Kraków, Poland
Website
iclab.plWebsite active
Electronic delivery address
AE:PL-57782-52195-AUVEH-16

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.84mMedianUSD 38.54kAverageUSD 2.32m
Net profit
This companyUSD 89.50kMedianUSD -1.56kAverageUSD -88.44k
Operating costs
This companyUSD 1.73mMedianUSD 56.03kAverageUSD 2.29m
Assets
This companyUSD 1.80mMedianUSD 119.99kAverageUSD 2.73m

Bank accounts

Registered as a VAT taxpayer on 2014-01-16. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

6 tenders recorded as contractor: 3 national ($149,957) and 3 EU ($7,791,410).

SubjectAmount
Dostawa sprzętu laboratoryjnego - aparatury kontrolnej i badawczej na potrzeby Wydziału Medycznego Katolickiego Uniwersytetu Lubelskiego Jana Pawła II z podziałem na 3 części.
$41,684
Dostawa urządzeń laboratoryjnych dla jednostek Uniwersytetu Przyrodniczego w Lublinie, z podziałem na 29 części.
$2,917
Wyposażenie Laboratorium Wysokorozdzielczego Obrazowania w Badaniach Translacyjnych, do stanowiska Zaawansowanych Technik Mikroskopii Wysokorozdzielczej – Zakup urządzeń w częściach
$7.2M

Public sector contracts

Iclab is the contractor in 2 public sector contracts, worth PLN 35.08k in total. They were signed with 2 public buyers.

Public buyerValue
Instytut Chemii Bioorganicznej Polskiej Akademii NaukPLN 900.32
Uniwersytet Im. Adama Mickiewicza w PoznaniuPLN 34,181

Authorized Representatives

Piotr Paweł Kasprzycki – President of the Management Board

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by a member of the management board. In the case of a management board consisting of two or more persons, joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Piotr Paweł Kasprzycki (53)
47$13,506.21100%

Beneficial owners

Person

Competitors

Name
MedappS.A.
SkinlabP.S.A.
EIT Rawmaterials Clc Eastsp. z o.o.
COS LabP.S.A.
Syventosp. z o.o.
Ecoverseasp. z o.o.
Zakład Genetyki Sądowejsp. z o.o.
GenxoneS.A.
Polbiotech Laboratoriumsp. z o.o.
Orphinic ScientificS.A.

Change history

DateEvent
2020-11-09Address change
2020-11-09Name change
2020-11-09PKD change
2020-09-01Business resumed
2015-12-30Business suspended

FAQ

Last updated: 2026-09-02